Sign in
GBIO Stock Price, Chart, Stats & News
Generation Bio Co.
Save
Generation Bio Co. (GBIO) does not currently pay a dividend.
35.98M
Market cap
–
Current P/E
7.87x
Forward P/E
GBIO chart
Fundamentals
Gross margin | 90.81% |
Operating margin | -553.92% |
Pretax margin | -410.13% |
Net margin | -410.13% |
Effective tax rate | – |
ROA | -51.38% |
ROE | -94.82% |
D/E | 0.52x |
Interest coverage ratio | – |
GBIO valuation
P/E | – |
P/S | 2.36x |
P/B | 0.71x |
P/CF | -0.32x |
P/FCF | -0.31x |
P/OCF | -0.32x |
PEG | -0.04x |
EV multiple | -0.54x |
About
Generation Bio Co. is a biotechnology firm focused on genetic therapies, working to devise treatments for both uncommon and widespread diseases. The company's current development pipeline includes multiple projects, with a particular emphasis on addressing rare and prevalent conditions affecting the liver and retina. Additionally, it directs its research towards disorders of skeletal muscle, the central nervous system, and oncology.
Similar securities
Based on sector and market capitalization
Report issue